New Wave Holdings subsidiary, Way of Will Inc. is pleased to announce its launch of high-quality mushroom products for Q1 2021

TORONTO, Jan. 14, 2021 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company” or “New…

Havn Life Sciences announces increase in Bought Deal Financing to $10 Million

VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) — Havn Life Sciences…

Havn Life Sciences Announces $5 Million Bought Deal Financing

VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) — Havn Life Sciences…

Havn Life Sciences to Supply Psychedelic Compounds to Clinical Studies Focused on Veterans and PTSD

Havn Life will collaborate on future clinical studies with Heroic Hearts Project…

Havn Life announces Voluntary Escrow of 6,300,000 Shares

The Voluntary Escrow serves further validates investors belief and support of Havn…

Havn Life Announces Launch of a Range of Natural Health Products

The 7 initial formulations are designed to support and enhance memory and…

Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder

TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…